Sponsorship Statement: This continuing medical education activity is sponsored by 
.
Support Statement: This activity is supported by an educational grant from 
.
Target Audience: This program is designed for dermatologists, oncologists, and other healthcare professionals involved in the treatment of patients with advanced basal cell carcinoma.
Learning Objectives: At the conclusion of this activity participants should be able to:
- Incorporate the most appropriate treatment regimens for advanced and metastatic basal cell carcinoma.
- Examine the hedgehog signaling pathway and evaluate emerging therapeutics that target this pathway in patients with advanced and metastatic basal cell carcinoma.
Faculty:
Therapeutic Strategies in Managing Advanced Basal Cell Carcinoma
Jean Y. Tang, MD, PhD
Assistant Professor of Dermatology
Stanford University
Stanford, California
Treatment Options in Managing Basal Cell Carcinoma
Axel Hauschild, MD
Professor of Dermatology
Head, Dermato-Oncology and Dermatologic Surgery
Department of Dermatology
University of Kiel
Senior Consultant Dermatologist
Department of Dermatology
University Hospital, Kiel Campus
Kiel, Germany
Understanding the Hedgehog Pathway
Aleksandar Sekulic, MD, PhD
Assistant Professor of Dermatology
Mayo Clinic
Assistant Professor, Integrated Cancer Genomics
The Translational Genomics Research Institute
Phoenix, Arizona
Comparing Recurrence Rates with Various Chemotherapeutic Agents
Karl Lewis, MD
Associate Professor of Medicine
Division of Medical Oncology
Department of Medicine
University of Colorado School of Medicine
Aurora, Colorado
Associate Director,
Melanoma Research Clinics
University of Colorado Denver
Denver, Colorado
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, July 30, 2012 to July 29, 2013.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch the videos, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Planning Committee and Faculty:
Aleksandar Sekulic, MD, PhD
Axel Hauschild, MD
Karl Lewis, MD
Jean Y. Tang, MD, PhD
External Reviewers:
Sanjiv S. Agarwala, MD
Ronald Codario, MD, FACP, FNLA
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Aleksandar Sekulic, MD, PhD
No relevant financial relationships to disclose.
Axel Hauschild, MD
Consulting Fees: Roche, Novartis
Fees for Non-CME Services: Roche, Novartis
Contracted Research: Roche, Novartis
Karl Lewis, MD
Consulting Fees: Genentech
Contracted Research: Genentech, Novartis
Jean Y. Tang, MD, PhD
Consulting Fees: Genentech
External Reviewers report the following relationship(s):
Sanjiv S. Agarwala, MD
Consulting Fees: Merck
Fees for Non-CME Services: Genentech, Bristol-Myers Squibb
Ronald Codario, MD, FACP, FNLA
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2012 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.